Antonio M. Gotto
About
In The Last Decade
Antonio M. Gotto
589 papers receiving 47.0k citations
Hit Papers
Peers
Comparison fields: 5 of 204
- Surgery 26.6k
- Endocrinology, Diabetes and Metabolism 16.4k
- Cardiology and Cardiovascular Medicine 11.7k
- Molecular Biology 9.9k
- Cancer Research 7.6k
Countries citing papers authored by Antonio M. Gotto
This map shows the geographic impact of Antonio M. Gotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio M. Gotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio M. Gotto more than expected).
Fields of papers citing papers by Antonio M. Gotto
This network shows the impact of papers produced by Antonio M. Gotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio M. Gotto. The network helps show where Antonio M. Gotto may publish in the future.
Co-authorship network of co-authors of Antonio M. Gotto
This figure shows the co-authorship network connecting the top 25 collaborators of Antonio M. Gotto. A scholar is included among the top collaborators of Antonio M. Gotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio M. Gotto. Antonio M. Gotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 41 | |
| 4 | High-density lipoproteins, reverse cholesterol transport and atherogenesis breakdown → | 144 |
| 5 | 13 | |
| 6 | 34 | |
| 7 | Statins: Do They Have Beneficial Effects Over and Above Their Actions on Lipids? | 0 |
| 8 | Abstract 11417: Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials | 2 |
| 9 | 16 | |
| 10 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein breakdown → | 2948 |
| 11 | Atherosclerosis: Evolving vascular biology and clinical implications. Introduction | 1 |
| 12 | The lipoprotein and coronary atherosclerosis study (LCAS) in context : assessing the benefits of lipid-lowering therapy | 2 |
| 13 | Treatment of patients with mild to moderate hypercholesterolemia: Lipoprotein and Coronary Atherosclerosis Study (LCAS) | 2 |
| 14 | AHA Consensus Panel Statement: Preventing Heart Attack and Death in Patients With Coronary Disease | 57 |
| 15 | Triglycerides : the role in diabetes and atherosclerosis | 1 |
| 16 | Isolation and characterization of the murine macrophage acetyl LDL receptor | 5 |
| 17 | Mono clonal antibodies to human apo lipo protein e | 2 |
| 18 | Obesity: A new approach to an old problem | 3 |
| 19 | Obesity, risk factor no. 1 | 1 |
| 20 | Insulin (I), glucagon (G), and the I/G ratio in carbohydrate (CHO) induced hyperlipemia | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.